Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.96 |
| ▸ | PPARG | P37231 | 8/20 | 0.96 |
| ▸ | F7 | P08709 | 7/20 | 0.96 |
| ▸ | F3 | P13726 | 7/20 | 0.96 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.96 |
| ▸ | PPARD | Q03181 | 6/20 | 0.96 |
| ▸ | PPARA | Q07869 | 6/20 | 0.96 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.96 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.96 |
| ▸ | MAPT | P10636 | 4/20 | 0.96 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 0.96 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.96 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.96 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.96 |
| ▸ | LMNA | P02545 | 3/20 | 0.96 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.96 |
| ▸ | HPGD | P15428 | 3/20 | 0.96 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.96 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.96 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.96 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL606016 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL7750567 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL452559 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL454567 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL10444556 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL7755119 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL14119798 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL7750573 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL15994740 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL29226 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024141286-A1 | (METH)ACRYLATED ISOCYANURATE MIXTURE, PROCESS FOR PREPARING SAME, AND USES THEREOF | ARKEMA FRANCE (FR) | 2024-07-04 | — | — | WO | claimed |
| CN-112996500-A | Compositions and methods for modulating ELOVL2 | 优美佳生物技术有限公司 | 2021-06-18 | — | — | CN | claimed |
| EP-3806840-A1 | COMPOSITION AND METHODS FOR MODULATION OF ELOVL2 | Youhealth Biotech, Limited (KY) | 2021-04-21 | — | — | EP | claimed |
| US-10125078-B1 | NSAID derivatives of omega-3 polyunsaturated acids as gamma secretase modulators | JIVA PHARMA INC. (US) | 2018-11-13 | — | — | US | claimed |
| US-9688613-B2 | Omegabalins, GABA derivatives of omega-3 polyunsaturated acids, their formulations and methods of use | JIVA PHARMA, INC. (US) | 2017-06-27 | — | — | US | claimed |
| US-9540307-B2 | Statins of omega-3 polyunsaturated acids for treating hypercholesterolemia | JIVA PHARMA, INC. (US) | 2017-01-10 | — | — | US | claimed |
| US-20160376223-A1 | Omegabalins, GABA Derivatives of Omega-3 Polyunsaturated Acids, Their Formulations and Methods of Use | JIVA PHARMA, INC. (US) | 2016-12-29 | — | — | US | claimed |
| US-9364465-B2 | Thiazolidinediones of omega-3 polyunsaturated acids as new insulin sensitizers for treating type2 diabetes | Jiva Pharma, Inc (US) | 2016-06-14 | — | — | US | claimed |
| US-20160051521-A1 | Thiazolidinediones of Omega-3 Polyunsaturated Acids as New Insulin Sensitizers for Treating Type2 Diabetes | JIVA PHARMA, INC. (US) | 2016-02-25 | — | — | US | claimed |
| US-20150374660-A1 | Ascorbate Esters of Omega-3 Fatty Acids and Their Formulations and Uses | JIVA PHARMA, INC. (US) | 2015-12-31 | — | — | US | claimed |
| US-20150344402-A1 | Omefibrates for Treating Dyslipidemia and Cardiovascular Disease | JIVA PHARMA, INC. (US) | 2015-12-03 | — | — | US | claimed |
| US-20150322032-A1 | Statins of Omega-3 Polyunsaturated Acids for Treating Hypercholesterolemia | JIVA PHARMA, INC. (US) | 2015-11-12 | — | — | US | claimed |
| WO-2014160936-A2 | THIAZOLIDINEDIONES OF OMEGA-3 POLYUNSATURATED ACIDS AS NEW INSULIN SENSITIZERS FOR TREATING TYPE2 DIABETES | JIVA PHARMA, INC. (US) | 2014-10-02 | — | — | WO | claimed |
| WO-2014134053-A1 | ASCORBATE ESTERS OF OMEGA-3 FATTY ACIDS | JIVA PHARMA, INC. (US) | 2014-09-04 | — | — | WO | claimed |
| EP-1888727-A1 | NEW DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS | Pronova BioPharma Norge AS (NO) | 2008-02-20 | — | — | EP | claimed |
| EP-1888728-A1 | FATTY ACID ANALOGUES, I.E. DHA DERIVATIVES FOR USES AS A MEDICAMENT | Pronova BioPharma Norge AS (NO) | 2008-02-20 | — | — | EP | claimed |
| WO-2006117668-A1 | FATTY ACID ANALOGUES, I.E. DHA DERIVATIVES FOR USES AS A MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2006-11-09 | — | — | WO | claimed |
| WO-2006117664-A1 | NEW DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS | PRONOVA BIOPHARMA NORGE AS (SE) | 2006-11-09 | — | — | WO | claimed |
| US-20250388720-A1 | ALKYD EMULSION HAVING IMPROVED WATER RESISTANCE AND IMPROVED HARDNESS DEVELOPMENT | ARKEMA FRANCE (FR) | 2025-12-25 | — | — | US | disclosed |
| US-5698594-A | ADMINISTERING MIXTURE OF ALL-Z OMEGA-3 FATTY ACIDS INCLUDING 5,8,11,14,17-EICOSAPENTAENOIC ACID, 4,7,10,13,16,19-DOCOSAHEXAENOIC ACID, 6,9,12,15,18-HENEICOSAPENTAENOIC ACID | NORSK HYDRO A.S (NO) | 1997-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160051521-A1 | Thiazolidinediones of Omega-3 Polyunsaturated Acids as New Insulin Sensitizers for Treating Type2 Diabetes | PPARD, PPARA, PPARG | ALDH1A1 2213/4885PPARG 3/4885F7 4550/4885 |
| US-20150344402-A1 | Omefibrates for Treating Dyslipidemia and Cardiovascular Disease | PPARA, PPARG, PPARD | ALDH1A1 2441/4885PPARG 2/4885F7 4412/4885 |
| US-20150374660-A1 | Ascorbate Esters of Omega-3 Fatty Acids and Their Formulations and Uses | ELOVL3, LIPA, LIPC | ALDH1A1 213/4885PPARG 568/4885F7 1033/4885 |
| US-10125078-B1 | NSAID derivatives of omega-3 polyunsaturated acids as gamma secretase modulators | PTGES3, PTGES, PTGER3 | ALDH1A1 2346/4885PPARG 108/4885F7 4816/4885 |
| US-20160376223-A1 | Omegabalins, GABA Derivatives of Omega-3 Polyunsaturated Acids, Their Formulations and Methods of Use | GABRB3, GABRA3, GABRA5 | ALDH1A1 1812/4885PPARG 228/4885F7 1076/4885 |
| US-20250388720-A1 | ALKYD EMULSION HAVING IMPROVED WATER RESISTANCE AND IMPROVED HARDNESS DEVELOPMENT | DRD1, DRD2, DRD3 | ALDH1A1 200/4885PPARG 1669/4885F7 2051/4885 |
| US-20150322032-A1 | Statins of Omega-3 Polyunsaturated Acids for Treating Hypercholesterolemia | HMGCR, ELOVL3, STARD3 | ALDH1A1 3793/4885PPARG 122/4885F7 3615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.